New cytogenetic abnormalities are frequent in AML and MDS relapsing after allogeneic hematopoietic cell transplantation (HCT).

被引：0
|
作者：
Pollyea, Daniel A.
Artz, Andrew S.
Stock, Wendy
Daugherty, Christopher
Godley, Lucy
Odenike, Olatoyosi M.
Rich, Elizabeth
Smith, Sonali M.
Zimmerman, Todd
Zhang, Yanming
Huo, Dezheng
Larson, Richard
Van Besien, Koen
机构：
[1] Cook Cty Hosp, Chicago, IL USA
[2] Univ Chicago Hosp, Chicago, IL 60637 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3675.3675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3675
引用
收藏
页码：1050A / 1050A
页数：1
相关论文
共 50 条
  • [41] Allogeneic Hematopoietic Stem Cell Transplantation for Follicular Lymphoma Relapsing after Autologous Transplantation
    Sakurai, Masatoshi
    Mori, Takehiko
    Shiratori, Souichi
    Wakayama, Toshio
    Uchida, Naoyuki
    Kobayashi, Hikaru
    Kanda, Junya
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Kondo, Eisei
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 512 - 512
  • [42] Access to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Acute Myeloid Leukemia (AML) in the State of Virginia
    Arora, Puja
    Duarte, Luis
    Mau, Lih-Wen
    Meyer, Christa
    Senneka, Mary
    Murphy, Elizabeth A.
    Desai, Raj
    Balkrishnan, Rasjesh
    Burns, Linda J.
    Ballen, Karen K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [43] Relationship between conditioning intensity and comorbidity in patients (Pts) with acute myeloid leukemia (AML) or myelodysplasia (MDS) receiving allogeneic hematopoietic cell transplantation (HCT).
    Sorror, M
    Storer, B
    Sandmaier, BM
    Maris, M
    Baron, F
    Maloney, D
    Scott, B
    Deeg, HJ
    Storb, R
    BLOOD, 2005, 106 (11) : 208A - 208A
  • [44] Current Status of Allogeneic Hematopoietic Cell Transplantation for MDS
    Xu, Feng
    Deeg, Joachim
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (22) : 3215 - 3221
  • [45] Long-Term Survival in Patients with AML or MDS Relapsed after Allogeneic Hematopoietic Cell Transplantation: Importance of Second Cell Therapy
    Brambilla, Corrado Zuanelli
    Ruiz, Josel D.
    Lobaugh, Stephanie M.
    Dahi, Parastoo B.
    Young, James W.
    Gyurkocza, Boglarka
    Shaffer, Brian C.
    Ponce, Doris M.
    Tamari, Roni
    Sanchez Escamilla, Miriam
    Flores, Nerea Castillo
    Politikos, Loannis
    Scordo, Michael
    Shah, Gunjan L.
    Cho, Christina
    Lin, Richard J.
    Maloy, Molly A.
    Devlin, Sean M.
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Perales, Miguel
    Giralt, Sergio A.
    Smith, Melody
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S97 - S98
  • [46] Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients
    Yang, Ting-Ting
    Song, Xiao-Lu
    Zhao, Yan-Min
    Ye, Bao-Dong
    Luo, Yi
    Xiao, Hao-Wen
    Chen, Yi
    Fu, Hua-Rui
    Yu, Jian
    Liu, Li-Zhen
    Lai, Xiao-Yu
    Ye, Yi-Shan
    Lan, Jian-Ping
    Huang, He
    Shi, Ji-Min
    ANNALS OF HEMATOLOGY, 2022, 101 (12) : 2731 - 2741
  • [47] Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients
    Ting-Ting Yang
    Xiao-Lu Song
    Yan-Min Zhao
    Bao-Dong Ye
    Yi Luo
    Hao-Wen Xiao
    Yi Chen
    Hua-Rui Fu
    Jian Yu
    Li-Zhen Liu
    Xiao-Yu Lai
    Yi-shan Ye
    Jian-Ping Lan
    He Huang
    Ji-Min Shi
    Annals of Hematology, 2022, 101 : 2731 - 2741
  • [48] Pathogenesis of relapse after allogeneic hematopoietic transplantation for AML
    Sierra, Jorge
    Carreras, Jose
    BONE MARROW TRANSPLANTATION, 2018, 53 : 810 - 811
  • [49] Mixed chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    de Lima, M
    Carrasco, A
    Lee, MS
    Saliba, R
    Glassman, A
    Anagnostopoulos, A
    Couriel, D
    Caldera, H
    Andersson, BS
    El-Zimaity, M
    Giralt, S
    Champlin, R
    BLOOD, 2003, 102 (11) : 707A - 707A
  • [50] 5-azacitidine in combination with donor lymphocyte infusions for the treatment of patients with MDS or AML relapsing after allogeneic stem cell transplantation
    Czibere, A.
    Graef, T.
    Bruns, I.
    Zohren, F.
    Germing, U.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S64 - S64
12345